QOL-08. PHASE II RANDOMIZED STUDY TO EVALUATE EFFICACY AND SATISFACTION OF ROLAPITANT PLUS ONDANSETRON VS. ONDANSETRON MONOTHERAPY IN PREVENTING NAUSEA/VOMITING FOR GLIOMAS RECEIVING RADIATION/ TEMOZOLOMIDE
Publication
, Conference
Affronti, ML; Patel, M; Severance, E; Loughlin, C; Bradbury, C; Herndon, JEII; Boyd, K; Lipp, ES; Friedman, HS; Desjardins, A; Johnson, M; Peters, KB
Published in: NEURO-ONCOLOGY
November 14, 2022
Duke Scholars
Published In
NEURO-ONCOLOGY
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 14, 2022
Volume
24
Issue
Suppl. 7
Start / End Page
vii242 / vii242
Location
Tampa Convention Center, Tampa Bay, FL
Conference Name
2022 Society for Neuro-Oncology’s 27th Annual Scientific Meeting and Education Day
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Affronti, M. L., Patel, M., Severance, E., Loughlin, C., Bradbury, C., Herndon, J. E. I. I., … Peters, K. B. (2022). QOL-08. PHASE II RANDOMIZED STUDY TO EVALUATE EFFICACY AND SATISFACTION OF ROLAPITANT PLUS ONDANSETRON VS. ONDANSETRON MONOTHERAPY IN PREVENTING NAUSEA/VOMITING FOR GLIOMAS RECEIVING RADIATION/ TEMOZOLOMIDE. In NEURO-ONCOLOGY (Vol. 24, pp. vii242–vii242). Tampa Convention Center, Tampa Bay, FL. https://doi.org/10.1093/neuroonc/noac209.935
Affronti, Mary Lou, Mallika Patel, Erin Severance, Charles Loughlin, Claire Bradbury, James E. I. I. Herndon, Kendra Boyd, et al. “QOL-08. PHASE II RANDOMIZED STUDY TO EVALUATE EFFICACY AND SATISFACTION OF ROLAPITANT PLUS ONDANSETRON VS. ONDANSETRON MONOTHERAPY IN PREVENTING NAUSEA/VOMITING FOR GLIOMAS RECEIVING RADIATION/ TEMOZOLOMIDE.” In NEURO-ONCOLOGY, 24:vii242–vii242, 2022. https://doi.org/10.1093/neuroonc/noac209.935.
Affronti ML, Patel M, Severance E, Loughlin C, Bradbury C, Herndon JEII, et al. QOL-08. PHASE II RANDOMIZED STUDY TO EVALUATE EFFICACY AND SATISFACTION OF ROLAPITANT PLUS ONDANSETRON VS. ONDANSETRON MONOTHERAPY IN PREVENTING NAUSEA/VOMITING FOR GLIOMAS RECEIVING RADIATION/ TEMOZOLOMIDE. In: NEURO-ONCOLOGY. 2022. p. vii242–vii242.
Affronti, Mary Lou, et al. “QOL-08. PHASE II RANDOMIZED STUDY TO EVALUATE EFFICACY AND SATISFACTION OF ROLAPITANT PLUS ONDANSETRON VS. ONDANSETRON MONOTHERAPY IN PREVENTING NAUSEA/VOMITING FOR GLIOMAS RECEIVING RADIATION/ TEMOZOLOMIDE.” NEURO-ONCOLOGY, vol. 24, no. Suppl. 7, 2022, pp. vii242–vii242. Manual, doi:10.1093/neuroonc/noac209.935.
Affronti ML, Patel M, Severance E, Loughlin C, Bradbury C, Herndon JEII, Boyd K, Lipp ES, Friedman HS, Desjardins A, Johnson M, Peters KB. QOL-08. PHASE II RANDOMIZED STUDY TO EVALUATE EFFICACY AND SATISFACTION OF ROLAPITANT PLUS ONDANSETRON VS. ONDANSETRON MONOTHERAPY IN PREVENTING NAUSEA/VOMITING FOR GLIOMAS RECEIVING RADIATION/ TEMOZOLOMIDE. NEURO-ONCOLOGY. 2022. p. vii242–vii242.
Published In
NEURO-ONCOLOGY
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 14, 2022
Volume
24
Issue
Suppl. 7
Start / End Page
vii242 / vii242
Location
Tampa Convention Center, Tampa Bay, FL
Conference Name
2022 Society for Neuro-Oncology’s 27th Annual Scientific Meeting and Education Day
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences